Jubilant Life Sciences (BOM:530019) today reported a fall of 36.36 percent in consolidated net profit of Rs 700 million for the quarter ended June 30, 2013, as compared to Rs 1,100 million in the same period last year.

As quoted in the press release:

”We are witnessing a strong underlying momentum in the Life Science Ingredients space, where volume growth has maintained course. The capacity enhancements are helping us scale up at an attractive pace and we are seeing pricing balance getting restored in some of our products,” said Shyam S Bhartia, chairman & managing director and Hari S Bhartia, co-chairman & managing director.

Read the full Jubilant Life Sciences (BOM:530019) press release here

Company News